HIGHBRIDGE CAPITAL MANAGEMENT LLC - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 54 filers reported holding BIOPLUS ACQUISITION CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$4,232
-80.9%
72,215
-51.1%
0.00%
-100.0%
Q2 2023$22,165
+61469.4%
147,765
-59.1%
0.00%0.0%
Q1 2023$36
+260.0%
361,165
-42.2%
0.00%
Q4 2022$10
-100.0%
624,955
-7.5%
0.00%
-100.0%
Q3 2022$61,000
-35.8%
675,9560.0%0.00%
-50.0%
Q2 2022$95,000
-36.7%
675,956
+3.9%
0.00%
-33.3%
Q1 2022$150,000650,8660.00%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Atalaya Capital Management LP 125,000$7,5000.01%
Q Global Advisors, LLC 195,489$110.01%
MMCAP International Inc. SPC 325,000$18,2000.01%
PERISCOPE CAPITAL INC. 867,072$48,5560.01%
MARSHALL WACE, LLP 78,611$2,543,0660.01%
HGC Investment Management Inc. 200,000$11,2000.00%
Spartan Fund Management Inc. 75,000$4,2000.00%
EHP Funds Inc. 125,186$7,0100.00%
COWEN AND COMPANY, LLC 522,096$29,2370.00%
Radcliffe Capital Management, L.P. 200,049$13,9430.00%
View complete list of BIOPLUS ACQUISITION CORP shareholders